These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 3080232

  • 1. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
    Vadi H, Drewinko B.
    Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232
    [Abstract] [Full Text] [Related]

  • 2. 1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking.
    Swinnen LJ, Barnes DM, Fisher SG, Albain KS, Fisher RI, Erickson LC.
    Cancer Res; 1989 Mar 15; 49(6):1383-9. PubMed ID: 2924295
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II)-induced DNA interstand cross-link removal and potentiation of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II) cytotoxicity by hydroxyurea and 1-beta-D-arabinofuranosylcytosine.
    Swinnen LJ, Ellis NK, Erickson LC.
    Cancer Res; 1991 Apr 15; 51(8):1984-9. PubMed ID: 2009517
    [Abstract] [Full Text] [Related]

  • 4. Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition.
    Bodenner DL, Dedon PC, Keng PC, Borch RF.
    Cancer Res; 1986 Jun 15; 46(6):2745-50. PubMed ID: 2870800
    [Abstract] [Full Text] [Related]

  • 5. In vitro pharmacodynamics of 1-beta-D-arabinofuranosylcytosine: synergy of antitumor activity with cis-diamminedichloroplatinum(II).
    Kern DH, Morgan CR, Hildebrand-Zanki SU.
    Cancer Res; 1988 Jan 01; 48(1):117-21. PubMed ID: 3334986
    [Abstract] [Full Text] [Related]

  • 6. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.
    Esaki T, Nakano S, Tatsumoto T, Kuroki-Migita M, Mitsugi K, Nakamura M, Niho Y.
    Cancer Res; 1992 Dec 01; 52(23):6501-6. PubMed ID: 1423296
    [Abstract] [Full Text] [Related]

  • 7. New platinum, titanium, and ruthenium complexes with different patterns of DNA damage in rat ovarian tumor cells.
    Frühauf S, Zeller WJ.
    Cancer Res; 1991 Jun 01; 51(11):2943-8. PubMed ID: 2032232
    [Abstract] [Full Text] [Related]

  • 8. Kinetics of DNA cross-linking in normal and neoplastic mouse tissues following treatment with cis-diamminedichloroplatinum(II) in vivo.
    Murray D, Jenkins WT, Meyn RE.
    Cancer Res; 1985 Dec 01; 45(12 Pt 1):6446-52. PubMed ID: 4063992
    [Abstract] [Full Text] [Related]

  • 9. Quiescent LLC-PK1 cells as a model for cis-diamminedichloroplatinum(II) nephrotoxicity and modulation by thiol rescue agents.
    Montine TJ, Borch RF.
    Cancer Res; 1988 Nov 01; 48(21):6017-24. PubMed ID: 2458831
    [Abstract] [Full Text] [Related]

  • 10. Interactions of cis-diamminedichloroplatinum(II) with 1-beta-D-arabinofuranosylcytosine in LoVo colon carcinoma cells.
    Fram RJ, Robichaud N, Bishov SD, Wilson JM.
    Cancer Res; 1987 Jul 01; 47(13):3360-5. PubMed ID: 3107809
    [Abstract] [Full Text] [Related]

  • 11. Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-beta-D-arabinofuranosylcytosine.
    Bergerat JP, Drewinko B, Corry P, Barlogie B, Ho DH.
    Cancer Res; 1981 Jan 01; 41(1):25-30. PubMed ID: 7192598
    [Abstract] [Full Text] [Related]

  • 12. Potentiation of cis-dichlorodiammineplatinum (II)-induced cytotoxicity by methylglyoxal.
    Dornish JM, Pettersen EO.
    Anticancer Res; 1989 Jan 01; 9(4):1137-42. PubMed ID: 2817795
    [Abstract] [Full Text] [Related]

  • 13. Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II).
    Meyn RE, Corry PM, Fletcher SE, Demetriades M.
    Cancer Res; 1980 Apr 01; 40(4):1136-9. PubMed ID: 7188882
    [Abstract] [Full Text] [Related]

  • 14. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
    Yang LY, Li L, Keating MJ, Plunkett W.
    Mol Pharmacol; 1995 May 01; 47(5):1072-9. PubMed ID: 7746274
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
    Grant S, Jarvis WD, Swerdlow PS, Turner AJ, Traylor RS, Wallace HJ, Lin PS, Pettit GR, Gewirtz DA.
    Cancer Res; 1992 Nov 15; 52(22):6270-8. PubMed ID: 1423273
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
    Minford J, Kerrigan D, Nichols M, Shackney S, Zwelling LA.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5583-93. PubMed ID: 6208999
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of cell-killing effects of 1-beta-D-arabinofuranosylcytosine and daunorubicin by a new computer-controlled in vitro pharmacokinetic simulation system.
    Kishi S, Goto N, Nakamura T, Ueda T.
    Cancer Res; 1999 Jun 01; 59(11):2629-34. PubMed ID: 10363985
    [Abstract] [Full Text] [Related]

  • 18. Combination chemotherapy in vitro. IV. Response of human colon carcinoma cells to combinations using cis-diamminedichloroplatinum.
    Bergerat JP, Green C, Drewinko B.
    Cancer Biochem Biophys; 1979 Jun 01; 3(4):173-80. PubMed ID: 575983
    [Abstract] [Full Text] [Related]

  • 19. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.
    Ali-Osman F, Berger MS, Rajagopal S, Spence A, Livingston RB.
    Cancer Res; 1993 Dec 01; 53(23):5663-8. PubMed ID: 8242621
    [Abstract] [Full Text] [Related]

  • 20. Schedule-dependent synergy and antagonism between high-dose 1-beta-D-arabinofuranosylcytosine and asparaginase in the L5178Y murine leukemia.
    Schwartz SA, Morgenstern B, Capizzi RL.
    Cancer Res; 1982 Jun 01; 42(6):2191-7. PubMed ID: 7074600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.